Pfizer–BioNTech vaccine approved for 12 to 15-year-olds in UK
The MHRA approved the Pfizer–BioNTech vaccine for use in children aged 12 to 15, citing comparable safety and efficacy to young adults and no new side effects.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthPfizer–BioNTech vaccine approved for 12 to 15-year-olds in UK
Sign in or subscribeBrowse free archive reportsThe MHRA approved the Pfizer–BioNTech vaccine for use in children aged 12 to 15, citing comparable safety and efficacy to young adults and no new side effects.